Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018135 · ClinicalTrials.gov registry record · NA
Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00018135 is a NA study that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00018135, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
Patients on hemodialysis tend to have chronic elevations in the level of phosphorus in the blood and a secondary increase in the iPTH level. This chronic elevation in iPTH can have adverse consequences, thus a variety of phosphate binders are given in an attempt to decrease the absorption of phosphorus present in the normal diet. Some preliminary studies have indicated that the iPTH level may change based on the amount of phosphorus present in a meal prior to any significant absorption of phosphorus. If this is true in hemodialysis patients, then the timing of the administration of phosphate binders in relation to the ingestion of meals needs to be considered
Interventions
- DRUG Sevelamer
- DRUG calcium acetate
- DRUG aluminum hydroxide
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018135
The ClinicalTrials.gov registry entry for NCT00018135 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sevelamer is the first listed.
NCT00018135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018135 about?
NCT00018135 is a clinical study titled "Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals". Patients on hemodialysis tend to have chronic elevations in the level of phosphorus in the blood and a secondary increase in the iPTH level. This chronic elevation in iPTH can have adverse consequences, thus a variety of phosphate binders are given in an attempt to decrease the absorption of phospho...
What is the current status of trial NCT00018135?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00018135?
The interventions under investigation include: Sevelamer (DRUG), calcium acetate (DRUG), aluminum hydroxide (DRUG).
Who is sponsoring clinical trial NCT00018135?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.